{"nct_id":"NCT05456685","title":"Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2022-09-28","start_date_type":"ACTUAL","primary_completion_date":"2026-11","primary_completion_date_type":"ESTIMATED","completion_date":"2026-11","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["ABBV"]}